Employees: NN (None)Legal category: 5470Size: PMECreation date: 2018-12-03 (7 years)Status: ActiveBusiness sector: Activités des sociétés holdingLocation: MONTREUIL (93100), Seine-Saint-Denis
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
AB PHARMA : revenue, balance sheet and financial ratios
AB PHARMA is a French company
founded 7 years ago,
specialized in the sector Activités des sociétés holding.
Based in MONTREUIL (93100),
this company of category PME
shows in 2024 a net income negative of -3 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
In 2024, AB PHARMA records a net loss of 3 k€. This deficit will reduce equity on the balance sheet.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-2 970 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at -1099%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -8%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
-1099.224%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
-8.451%
Solvency indicators evolution AB PHARMA
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2021
2022
2023
2024
Debt ratio
6147.239
-3591.923
-1571.628
-1313.586
-1099.224
Financial autonomy
1.601
-2.792
-6.659
-7.036
-8.451
Repayment capacity
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
-1099.222024
2022
2023
2024
Q1: 0.01
Med: 8.77
Q3: 62.6
Excellent
In 2024, the debt ratio of AB PHARMA (-1099.22) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
-8.45%2024
2022
2023
2024
Q1: 15.71%
Med: 62.26%
Q3: 91.3%
Average
In 2024, the financial autonomy of AB PHARMA (-8.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Positioning of AB PHARMA in its sector
Comparison with sector Activités des sociétés holding
Similar companies (Activités des sociétés holding)
Compare AB PHARMA with other companies in the same sector:
The revenue of AB PHARMA is not publicly disclosed (confidential accounts filed with INPI).
Is AB PHARMA profitable?
AB PHARMA recorded a net loss in 2024.
Where is the headquarters of AB PHARMA ?
The headquarters of AB PHARMA is located in MONTREUIL (93100), in the department Seine-Saint-Denis.
Where to find the tax return of AB PHARMA ?
The tax return of AB PHARMA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does AB PHARMA operate?
AB PHARMA operates in the sector Activités des sociétés holding (NAF code 64.20Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart